Macroscopic Portal Vein Thrombosis in HCC Patients
暂无分享,去创建一个
B. Carr | H. Akkız | F. Doran | A. Uygun | M. Demir | Tolga Akçam | N. Örmeci | A. Demir | M. Yücesoy | V. Guerra | H. Balli | A. Delik | A. Bektaş | E. Altıntaş | S. Yılmaz | M. Kılıç | A. Sonsuz | Y. Tokat | Ümit Karaoğullarından | S. Kuran | B. Arslan | H. Şimşek | K. Y. Polat | O. Üsküdar | K. Yalcin | S. Tokmak | Abdulalh Ülkü | Halil İbrahim Bahçeci | Nazım Ekinci | Ayşegül Harmancı Özakyol
[1] D. Yang,et al. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] J. Bruix,et al. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies. , 2017, Journal of hepatology.
[3] B. Carr,et al. Serum Albumin Levels in Relation to Tumor Parameters in Hepatocellular Carcinoma Patients , 2017, The International journal of biological markers.
[4] J. Marrero,et al. Vascular Invasion and Metastasis is Predictive of Outcome in Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[5] Y. Choi,et al. Macrovascular invasion is not an absolute contraindication for living donor liver transplantation , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] B. Carr,et al. Erratum to: Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis , 2016, Digestive Diseases and Sciences.
[7] K. Boudjema,et al. Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[8] B. Carr,et al. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis , 2016, Digestive Diseases and Sciences.
[9] P. Ambrosino,et al. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma. , 2015, World journal of gastroenterology.
[10] M. Deng,et al. Reappraisal of Evidence of Microscopic Portal Vein Involvement by Hepatocellular Carcinoma Cells with Stratification of Tumor Size , 2015, World Journal of Surgery.
[11] S. Saab,et al. Management of hepatocellular carcinoma with portal vein thrombosis. , 2015, World journal of gastroenterology.
[12] C. Sakakura,et al. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. , 2015, World journal of gastroenterology.
[13] Jia-Hui Chu,et al. Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma , 2014, Cellular Physiology and Biochemistry.
[14] J. Lee,et al. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion , 2013, World Journal of Surgical Oncology.
[15] W. Lau,et al. Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: The Emerging Role for Radioembolization Using Yttrium-90 , 2013, Oncology.
[16] S. Ahn,et al. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels , 2012, European journal of gastroenterology & hepatology.
[17] H. Tajiri,et al. Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma , 2012, Medical Oncology.
[18] Ziqiu Wang,et al. Differential Effects of Vitamin K1 on AFP and DCP Levels in Patients with Unresectable HCC and in HCC Cell Lines , 2011, Digestive Diseases and Sciences.
[19] Zu-hua Gao,et al. Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway. , 2011, European journal of cancer.
[20] W. Irish,et al. Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis. , 2010, Hepato-Gastroenterology.
[21] R. Branch,et al. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study , 2010, Hepatology international.
[22] J. Llovet,et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. , 2009, Gastroenterology.
[23] Ming-Hui Chen,et al. Vitamin K2 Inhibits the Growth of Hepatocellular Carcinoma via Decrease of Des-Gamma-Carboxy Prothrombin , 2008, Chemotherapy.
[24] A. Vercelli,et al. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma , 2008, European Radiology.
[25] A. Benson,et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis , 2007, Hepatology.
[26] M. Kudo,et al. Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma , 2007, Journal of Gastroenterology.
[27] E. Gregoire,et al. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series , 2006, Journal of Gastrointestinal Surgery.
[28] H. Wang,et al. Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.
[29] Y. Shiratori,et al. Des-γ-carboxy Prothrombin Is a Potential Autologous Growth Factor for Hepatocellular Carcinoma* , 2005, Journal of Biological Chemistry.
[30] Y. Shiratori,et al. Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation , 2004, Hepatology.
[31] R. Tsuchiya,et al. Prediction of Invasive Activities in Hepatocellular Carcinomas with Special Reference to α-Fetoprotein and Des-γ-carboxyprothrombin , 2003 .
[32] Y. Shiratori,et al. Des‐γ‐carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma , 2001, Cancer.
[33] P. Ferenci,et al. Hepatocellular carcinoma in Central Europe: prognostic features and survival , 2001, Gut.
[34] Bernardino,et al. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma , 2000, Hepatology.
[35] M. Tublin,et al. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. , 1997, AJR. American journal of roentgenology.
[36] M. Persico,et al. Ultrasound‐guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: Results in 15 patients , 1995, Journal of gastroenterology and hepatology.
[37] Ziqiu Wang,et al. The growth inhibitory effects of vitamins K and their actions on gene expression , 1995, Hepatology.
[38] K. Sugimachi,et al. Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma. , 1995, Surgery.
[39] G. Dodd,et al. Percutaneous biopsy of portal vein thrombus: a new staging technique for hepatocellular carcinoma. , 1993, AJR. American journal of roentgenology.
[40] C. Taylor,et al. Computed tomography in the evaluation of the portal venous system. , 1992, Journal of clinical gastroenterology.
[41] Dong-hao Wu,et al. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma , 2014, Tumor Biology.
[42] R. Tsuchiya,et al. Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin. , 2003, Japanese journal of clinical oncology.
[43] Bellia Mario,et al. Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80) , 2000 .
[44] C. Avellini,et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study , 1998, Journal of Cancer Research and Clinical Oncology.